UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000029288
Receipt number R000033477
Scientific Title To evaluate the efficacy and safety of once-weekly DPP-4 inhibitor: Omarigliptin and the differences between Omarigliptin and once or twice-daily DPP-4 inhibitors for the treatment of type 2 diabetes
Date of disclosure of the study information 2017/09/29
Last modified on 2020/09/23 18:23:07

No. Disposal Last modified on Item of update
1 Insert 2017/09/25 22:57:00
2 Update 2018/09/26 22:42:50 Research ethics review
3 Update 2018/09/26 22:52:33 Recruitment status
Anticipated trial start date
Last follow-up date
4 Update 2018/09/26 22:54:48 Anticipated trial start date
5 Update 2019/03/27 14:25:56 Number of participants that the trial has enrolled
6 Update 2019/09/22 09:40:47 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Email2
Email3
Organization
Organization
Address
Address
Tel
Email
7 Update 2019/09/22 09:47:43 Date of IRB
Last follow-up date
8 Update 2020/03/27 10:24:00 Email1
Email3
Email
9 Update 2020/09/23 16:57:56 Recruitment status
10 Update 2020/09/23 17:11:32 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
11 Update 2020/09/23 17:52:39 Results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
12 Update 2020/09/23 17:54:39 Primary outcomes
13 Update 2020/09/23 18:01:35 Basic design
Randomization
Randomization unit
Control
No. of arms
Interventions/Control_2
Interventions/Control_2
14 Update 2020/09/23 18:22:44 Publication of results
Baseline Characteristics
Participant flow
Outcome measures
15 Update 2020/09/23 18:23:07 Publication of results